CN108114115A - A kind of emulsifiable paste for being used for acne and skin barrier injury repair and its preparation method and application - Google Patents
A kind of emulsifiable paste for being used for acne and skin barrier injury repair and its preparation method and application Download PDFInfo
- Publication number
- CN108114115A CN108114115A CN201810108054.8A CN201810108054A CN108114115A CN 108114115 A CN108114115 A CN 108114115A CN 201810108054 A CN201810108054 A CN 201810108054A CN 108114115 A CN108114115 A CN 108114115A
- Authority
- CN
- China
- Prior art keywords
- parts
- acne
- skin barrier
- emulsifiable paste
- injury repair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of emulsifiable pastes for acne and skin barrier injury repair, include the raw material that following parts by weight match:12~15 parts of oldenlandia diffusa, 12~15 parts of climbing groundsel, 12~15 parts of Chinese holly, 12~15 parts of Chinese violet, 8~10 parts of felwort, 8~10 parts of the root bark of shaggy-fruited dittany, 8~10 parts of barberry, 6~8 parts of Eucalyptus globulus Labill leaf, 6~8 parts of peppermint, 10~12 parts of loguat leaf, 8~10 parts of rhizoma atractylodis, 6~8 parts of piper cubeba, 6~8 parts of eclipta, 6~8 parts of Herba Cistanches, 10~12 parts of Radix Paeoniae Alba, 8~10 parts of bush, 8~10 parts of dragon's blood, 8~10 parts of catechu.Above-mentioned raw materials are extracted, filter, are prepared by mixing into emulsifiable paste with auxiliary material after alcohol precipitation, are applied as Retinoids, Retin-A, Renova, Accutane, can treat both principal and secondary aspect of disease, pay attention to prognosis, prevent from recurring.
Description
Technical field
The present invention relates to traditional Chinese medicine for outer use technical fields, are repaiied more particularly to one kind for acne and skin barrier damage
Multiple emulsifiable paste and its preparation method and application.
Background technology
Acne is the common disease of Dermatology Outpatient Department, and skin lesion shows as pinhead-sized hair follicle sample papule, can be with redness
The inflammation performance of hot pain, the sebum content of visible granulated slag sample after extruding have certain self limiting.Western medicine think this disease with
Endocrine, pilosebaceous duct angling, infection, immune and inherent cause are related.This disease incidence is higher, in puberty men and women
In more so.Since this disease influences beauty, therefore patient often voluntarily squeezes or scratches papule, causes secondary skin lesion, and forms skin
Barrier is damaged, and performance includes local hemorrhage, ulcer formation, general red, swelling, itch etc.;If accumulative skin corium, can form after healing
Scar, influences patient's beauty, and harm is larger.
In Surgery of Chinese Medicine, the etiology and pathogenesis of acne can be summarized as wind and heat in the lung meridian and fumigate face;Overfeeding delicious food, stomach are wet
Heat, upper steaming face;Deficiency of spleen-QI, dysfunction of the spleen in transportation and transformation, it is wet it is turbid in stop, strongly fragrant longization heat, the bright body fluid of heat, into phlegm, the phlegm wet stasis of blood is stagnant to coagulate refining liquid
Stagnant skin.Shi Re Bing Pian condensation face is for mark, symptomatic treatment in acute condition in this disease;At all hot and suffocating for lung channel, the wet turbid tired spleen of disease, kidney
Asthenic yin and flaring up of deficient fire;Local qi and blood stagnation after being ill, forms patch, and blood-deficiency and wind-dry is sent out as itch or even acne print.
The prior art has local topical drug, oral antibiotic, oral isotretinoin, anti-hero for the therapy of acne
Hormone therapy, oral glucocorticoid, laser therapy etc..Wherein local topical drug include tretinoin, benzoyl peroxide,
Antibiotics (clindamycin, erythromycin, chloramphenicol etc.), azelaic acid, sulphur lotion etc.;Oral antibiotic include Tetracyclines,
Macrolides;Anti-androgen therapy such as oral contraceptive Compound Cyproterone Acetate Tablets.Tretinoin medicines can accelerate epidermis
Cutin comes off, and has certain irritation, and long-term a large amount of uses can make keratoderma too thin and cause allergy and then induce more
More skin problems.Benzoyl peroxide can cause some patientss shouting pain, itch occur, tighten sense and burn feeling, erythema, water occur
Swollen, dry and furfur adverse reaction.Clindamycin can cause the allergic reactions such as dry skin, local excitation, fash, and part
Patient is present with the situation of acne recurrence after deactivated.Erythromycin, chloramphenicol, azelaic acid, the external application of sulphur lotion mainly play
The effect of its antibacterial anti-inflammatory for acne caused by internal cause, is also possible to cause recurrence after deactivated.Oral tetracycline antibiotic
Gastrointestinal reaction, hepatic lesion, hypovitaminosis, renal toxicity can be caused, and have irreversible influence to bone, tooth growth, do not applied to
In adolescent acne patient's long-time service.Oral macrolide antibiotics can cause enteron aisle reaction, hepatic lesion, allergy,
Cardiac toxic and hematotoxicity.Oral contraceptive significantly affects the generation of body hormone, is unsuitable for male, and can cause patient
Occur breast tenderness, pain, secretion, have a headache, be in a very depressed state, do not tolerate contact lenses, Nausea and vomiting, vaginal fluid change,
Various skin diseases, fluid retention, weight gain, allergic reaction, dysfunction of liver, serum triglyceride rise.Sugared cortical hormone
Element can cause water, salt, sugar, protein and fat metabolic disturbance, and weaken Abwehrkraft des Koepers, hinder tissue repair, delay tissue
Healing inhibits upgrowth and development of children, and heavy dose should not be pregnant using glucocorticoid person.Laser therapy has certain wound
Property, and the root problem of endogenous acne cannot be solved.Above for acne the prior art there are certain side effect and
It cannot solve the problems, such as the internal cause of acne, the possibility that there is recurrence after stopping.
The content of the invention
For certain side effect exists in the prior art and cannot solve the problems, such as the internal cause of acne, stop after existing it is multiple
The problem of possibility of hair, the present invention provide a kind of emulsifiable paste for acne and skin barrier injury repair.
And the present invention also provides a kind of preparation methods for the emulsifiable paste for being used for acne and skin barrier injury repair.
And acne drug neck is being prepared for the emulsifiable paste of acne and skin barrier injury repair the present invention also provides a kind of
The application in domain.
To achieve the above object of the invention, the embodiment of the present invention employs following technical solution:
A kind of emulsifiable paste for acne and skin barrier injury repair includes the raw material of following parts by weight proportioning:White flower
12~15 parts of HERBA HEDYOTIS DIFFUSAE, 12~15 parts of climbing groundsel, 12~15 parts of Chinese holly, 12~15 parts of Chinese violet, 8~10 parts of felwort,
8~10 parts of the root bark of shaggy-fruited dittany, 8~10 parts of barberry, 6~8 parts of Eucalyptus globulus Labill leaf, 6~8 parts of peppermint, 10~12 parts of loguat leaf, rhizoma atractylodis 8~10
Part, 6~8 parts of piper cubeba, 6~8 parts of eclipta, 6~8 parts of Herba Cistanches, 10~12 parts of Radix Paeoniae Alba, 8~10 parts of bush, dragon's blood 8~10
Part, 8~10 parts of catechu.
It is provided by the present invention for the emulsifiable paste of acne and skin barrier injury repair synthesis sample compared with the prior art
With prognosis, clearing away heat-damp and expelling toxic material controls its mark suddenly, and prognosis is paid attention in three dirty slow Zhi Qiben of reconciliation lung spleen kidney, nourshing blood and promoting blood circulation, and fever and chills match,
Combined into side, the benefits of playing clearing heat and detoxicating sore, clearing damp dispelling wind, clearing lung-heat eliminating dampness, YIN and YANG balance regulating altogether, antibiosis in the prior art is avoided
The side effect that element, chemicals are brought, solves the internal cause of acne, and avoids recurring.
And the embodiment of the present invention additionally provides a kind of system of above-mentioned emulsifiable paste for being used for acne and skin barrier injury repair
Preparation Method, the emulsifiable paste for acne and skin barrier injury repair is by raw material is extracted, filtering, is mixed with auxiliary material after alcohol precipitation
It is prepared.
The preparation method improves the bioavilability of active ingredient in raw material, is allowed to be more readily absorbed and plays effect
Fruit is made after emulsifiable paste and is easy to use, and can by emulsifiable paste the features such as ductility is good, easy infiltration, promote in raw material effectively into
Divide and play a role.
The embodiment of the present invention also provides the above-mentioned emulsifiable paste for being used for acne and skin barrier injury repair in preparation acne drug
The application in field.
Emulsifiable paste provided by the present invention for treat acne when, raw material therein can complex treatment sample pay attention to again in advance
Afterwards, avoid recurring, and manufactured emulsifiable paste can also aid in the effect for playing active ingredient in raw material, and make convenient for patients with acne
With so as to preferably play the role for the treatment of acne and repair skin barrier.
Description of the drawings
Fig. 1 is the experiment skin progress pathological section figure that mouse is normally organized in zoopery;
Fig. 2 is that the experiment skin of model group mouse in zoopery carries out pathological section figure;
Fig. 3 is that the experiment skin of 1 group of mouse of embodiment in zoopery carries out pathological section figure;
Fig. 4 is that the experiment skin of 3 groups of mouse of embodiment in zoopery carries out pathological section figure;
Fig. 5 is that the experiment skin of positive control group mice in zoopery carries out pathological section figure.
Specific embodiment
In order to make the purpose , technical scheme and advantage of the present invention be clearer, below in conjunction with specific embodiment, to this
Invention is further elaborated.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, not
For limiting the present invention.
The embodiment of the present invention provides a kind of emulsifiable paste for acne and skin barrier injury repair, including following parts by weight
The raw material of proportioning:12~15 parts of oldenlandia diffusa, 12~15 parts of climbing groundsel, 12~15 parts of Chinese holly, 12~15 parts of Chinese violet,
8~10 parts of felwort, 8~10 parts of the root bark of shaggy-fruited dittany, 8~10 parts of barberry, 6~8 parts of Eucalyptus globulus Labill leaf, 6~8 parts of peppermint, loguat leaf 10~
12 parts, 8~10 parts of rhizoma atractylodis, 6~8 parts of piper cubeba, 6~8 parts of eclipta, 6~8 parts of Herba Cistanches, 10~12 parts of Radix Paeoniae Alba, bush 8~
10 parts, 8~10 parts of dragon's blood, 8~10 parts of catechu.
During pathogenesis of acne, skin lesion red and swollen heat pain, for fear of beauty has single generation, also there is comprehensive general hair, patient is often anxious
Irritated, worried anxiety or even frustration close family plug window, therefore alleviate skin lesion, and it is anxious for mark to repair skin barrier.In the present invention
Oldenlandia diffusa is cold in nature, bitter, sweet, returns stomach, large intestine, small intestinl channel, clearing heat and detoxicating, dampness removing is treating stranguria, available for carbuncle sore tumefacting virus;A thousand li
Photosensitiveness is trembled with fear, bitter, return lung, Liver Channel, and clear thermolysin clears liver and improve vision, removing dampness through diuresis and relieving itching, and the carbuncle swells sore that using fresh herb can control heat toxin heap soil or fertilizer over and around the roots knot is itched;
Chinese holly is cool in nature, bitter, puckery, return lung, large intestine, bladder warp, clearing heat and detoxicating, myogenic sore, cooling blood and hemostasis;Chinese violet is cold in nature,
Bitter, pungent, converge to heart and liver channels, clearing heat and detoxicating, cool blood detumescence.Oldenlandia diffusa, climbing groundsel, Chinese holly are clearing heat and detoxicating, Chinese violet
Four medicine bitter colds are cool to rush down, and is all monarch drug in a prescription, controls the mark that heat toxin stops up Sheng.
The acne state of an illness is touching, and delay is refractory, is for caused by damp evil.Felwort is cold in nature, bitter, Return liver, gallbladder channel, and heat-clearing is dry
Wet, purging the liver of pathogenic fire courage fire has antibacterial and anti-inflammatory effect, can inhibit the inflammatory reaction that acne propionic acid feels mediation;The root bark of shaggy-fruited dittany is cold in nature,
Bitter, returns spleen, stomach, bladder warp, heat-clearing and damp-drying drug, detoxifying and relieving itching are outstanding kind except skin is damp and hot;Barberry is cold in nature, bitter, Return liver, stomach,
Large intestine channel, heat-clearing and damp-drying drug, purging intense heat and detonicating can treat heat toxin sore carbuncle.Felwort, the root bark of shaggy-fruited dittany, barberry are all ministerial drug, wash away middle coke
It is damp and hot, break off the source of damp and hot upper steaming, the clearing heat and detoxicating work(of principal drug assistance.
Acne hair closes skin in face skin, lung five body constituents.Eucalyptus globulus Labill leaf is cold in nature, bitter, pungent, return lung, stomach, spleen, Liver Channel, dispelling wind solution
Table, clearing heat and detoxicating, desinsection is antipruritic, can treat ulcerative carbuncle pyogenic infections, eczema mange;Peppermint is cool in nature, acrid flavour, return lung, Liver Channel, life evacuation
Wind-heat, refresh oneself, throat, promoting eruption is antipruritic, soothing liver-qi stagnation.Eucalyptus globulus Labill leaf and peppermint gently rise clearly floating, take all drug effect power and go directly lung channel,
It is to make medicine.
Acne sheet is wind and heat in the lung meridian, and damp-heat retention in spleen is fire excess from yin deficiency, if controlling its mark on foot, probably stays illness, sitting and lying daily life, sweating
Work as wind, Exogenous and internal injuries, addiction to greasy and sweet foods, and can fall ill, doctor is unexamined basic, and increasing is worried on foot for sufferer, therefore we and the root for paying attention to disease
This prevention adjusts three dirty function of lung spleen kidney.Loguat leaf cold nature, bitter attach to the lung and stomach meridians, can removing heat from the lung to relieve cough, evacuate lung wind
Heat has anti-inflammatory effect, can mitigate the inflammatory reaction during pathogenesis of acne, reduce the generation of skin lesion, be for ministerial drug.
The cold and cool medicine in full side is exaggerated, and probably consumes impairment of the spleen sun, and spleen sun is not transported, phlegm wet condensation, not only phlegm wet condenses, more probably it is cold and cool it
Product, which are upset one's stomach, to be impairment of the kidney, therefore selects rhizoma atractylodis, piper cubeba with warming spleen and stomach for dispelling cold, drying damp and strengthening spleen.Rhizoma atractylodis are warm-natured, acrid flavour, hardship, returns spleen, stomach, Liver Channel,
It is drying damp and strengthening spleen, expelling wind and clearing away cold;Piper cubeba is warm-natured, acrid flavour, returns spleen, stomach, kidney, bladder warp, warming spleen and stomach for dispelling cold, promoting qi circulation and relieving pain.Rhizoma atractylodis, Bi
Clear eggplant restricts the bitter cold pharmacological property of the medicine of the monarch and his subjects jointly, and can temperature sun and help the transporting of spleen, temper is good for fortune, and damp evil solves then, and patient's condition obtains
It is good.In addition, rhizoma atractylodis have hepatoprotective effect, in the present invention with rhizoma atractylodis, the hepatic injury as caused by Chinese medicine is possible can be prevented, together
When also have synergistic effect with felwort, enhance its antibacterial bacteriostatic effect.
Eclipta is cold in nature, sweet in flavor, sour, returns liver and kidney channel, nourishing kidney-yin, cooling blood and hemostasis;Herba Cistanches are warm-natured, sweet in flavor, salty, return kidney,
Large intestine channel, kidney-replenishing, benefiting essence-blood.Eclipta and Herba Cistanches negative and positive and tune restrict the flaring up of deficient fire of the deficiency of the kidney yin, be for adjutant,
By the adjusting to kidney, realize the adjusting to hypothalamic-pituitary-adrenal (sexual gland/thyroid gland) axis, avoid the big of male sex hormone
Amount discharges and stimulates a large amount of sebum secreteds of sebaceous glands, achievees the purpose that reduce pathogenesis of acne.Herba Cistanches also have strengthen immunity
Effect, in we, it is possible to reduce a large amount of multiplication of patient's propionibacterium acnes safeguard the balance of skin surface flora.
Acne has certain self limiting, but may result in skin corium due to the improper extruding of patient in pathogenic process
It is damaged and healing cicatrization occurs, therefore during treatment, it should pay attention to the reparation of skin barrier.The skin barrier of narrow sense is usually
Refer to epidermis, particularly the mechanical barrier structure of cuticula.Mechanical barrier is directly contacted with the external world, is had to extraneous various damages
The protective action of wound, while also have the integrality for maintaining skin, prevent internal epidermis and the substances such as intradermal moisture and lipid from losing
The function of mistake.During pathogenesis of acne, skin barrier structural proteins, lipidosis cause skin barrier function by
Damage, can lead acnegenic recurrent exerbation, further aggravate the damage of skin barrier.Bush is mild-natured, sweet in flavor, salty, pungent, the thoughts of returning home,
Liver Channel, promoting blood circulation, swelling and pain relieving;Dragon's blood is mild-natured, sweet in flavor, salty, converge to heart and liver channels, analgesic therapy of invigorating blood circulation, removing blood stasis and hemostasis, myogenic sore,
With anti-inflammatory pain-stopping effect, the infection of ulcer surface can be prevented;Catechu cold nature, bitter, puckery, distributed in heart and lung channels, promoting blood circulation and stopping pain, only
Blood myogenic, hygroscopic sore are controlled sore and are not held back, can be with dragon's blood with use.Bush, dragon's blood, catechu synergistic effect can promoting blood circulation and removing blood stasis, detumescences
Analgesic therapy, myogenic sore, treatment carbuncle sore tumefacting virus.In addition, the anti-inflammatory pain-stopping effect of dragon's blood can act synergistically with felwort, rhizoma atractylodis, increase
The effect of strong resisting pathogenic microbes.Radix Paeoniae Alba nourishing blood for regulating menstruation, the analgesic of soft liver, in morbidity and pre- later stage, patient often feels pruitus,
Migration is indefinite, spins up rotation and goes out, is haunted for ailment said due to cold or exposure, and Radix Paeoniae Alba takes the meaning of " control wind and first control blood, blood wind goes out certainly ", and nourshing blood and promoting blood circulation stops
Itch analgesic therapy;Radix Paeoniae Alba has the soothing the liver effect of soft liver concurrently, can the anxiety that is generated due to the state of an illness of reduction of patient.
To sum up, we are clearing heat and detoxicating, can suddenly take stopgap measures, clearing lung-heat temperature spleen, YIN and YANG balance regulating, radical treatment in chronic case, repair skin barrier, weight
Depending on prognosis, prevent from recurring.
It is further preferred that the felwort, the root bark of shaggy-fruited dittany, barberry, loguat leaf, rhizoma atractylodis, piper cubeba, eclipta, meat desert
Rong, bush, dragon's blood, catechu are the medicinal material after processing, the oldenlandia diffusa, climbing groundsel, Chinese holly, Chinese violet, blue gum
Leaf, peppermint, Radix Paeoniae Alba are the fresh medicine material not processed after cleaning.Due to oldenlandia diffusa, climbing groundsel, Chinese holly, Chinese violet,
Eucalyptus globulus Labill leaf, peppermint, Radix Paeoniae Alba contain volatile component, can not high-temperature process, therefore using fresh herb.
It is further preferred that the rhizoma atractylodis are wheat bran rhizoma atractylodis, drying damp and strengthening spleen effect is stronger;The eclipta is eclipta
Charcoal, convergence astringent method hemostasia effect is more preferably.
It is further preferred that the auxiliary material of following parts by weight proportioning is further included in formula:51~55 parts of distilled water, sorbierite
24~28 parts, 0.04~0.06 part of natrium adetate, 3.5~4.0 parts of propylene glycol, 7~9 parts of atoleine, PEG-30 dimerization hydroxyls
2.6~3.0 parts of base stearate, single 2.6~3.0 parts of glyceryl isostearate, 0.2~0.3 part of ethylparaben.Above-mentioned auxiliary material
In, distilled water, sorbierite, natrium adetate, propylene glycol are water phase, can extract acquired solution with raw material and mix, atoleine,
It is oil phase to be sustained emulsifier, single glyceryl isostearate, ethylparaben, and mutually w/o type lotion can be formed with water.
It is further preferred that include the auxiliary material of following parts by weight proportioning:53 parts of distilled water, 26 parts of sorbierite, edetic acid(EDTA)
0.05 part of disodium, 3.75 parts of propylene glycol, 8 parts of atoleine, 2.8 parts of PEG-30 dimerization hydroxy stearic acid ester, single isostearic acid is sweet
2.8 parts of grease, 0.25 part of ethylparaben.
It is further preferred that the sustained release emulsifier is included for PEG-30 dimerization hydroxy stearic acid ester, sesquialter oleic acid sorb
At least one of smooth, poloxamer.Three kinds of emulsifiers can the water oil interface of lotion formed membranaceous material, and incite somebody to action
Including drug tight among phase, so as to achieve the effect that sustained release.
The embodiment of the present invention also provides a kind of preparation method for the emulsifiable paste for being used for acne and skin barrier injury repair, described
For the emulsifiable paste of acne and skin barrier injury repair by the raw material is extracted, filtering, mixes system with the auxiliary material after alcohol precipitation
It is standby to form.
The preparation method process greatly improves the bioavilability of active ingredient in raw material, more by abstraction process
It is easy to absorb and play effect;By the content for concentrating to reduce solvent in extracting solution, it is possible to reduce ethyl alcohol during alcohol precipitation uses
Amount;Water-insoluble impurity is removed by alcohol precipitation;It is easy to use by being prepared by mixing into emulsifiable paste with auxiliary material, and can be by emulsifiable paste
The features such as ductility is good, easy infiltration, active ingredient in raw material is promoted to play a role.Specifically, the step is:
Step a, each raw material is weighed by above-mentioned raw materials proportioning, by felwort, the root bark of shaggy-fruited dittany, barberry, loguat leaf, rhizoma atractylodis, Bi
Clear eggplant, eclipta, Herba Cistanches, bush, dragon's blood, catechu add the water of 7~10 times of the material quality to decoct 40~50 minutes, add in
Oldenlandia diffusa, climbing groundsel, Chinese violet, Chinese holly, Eucalyptus globulus Labill leaf, peppermint, Radix Paeoniae Alba continue decoction 10~20 minutes, filtering, to
Add water to cook 1~2 time in filter residue, every time 1~1.5 it is small when, filtering merges all filtrates;
Step b, concentrate is obtained after filtrate is concentrated, adds in ethyl alcohol, stands, takes supernatant;
Step c, each auxiliary material is weighed by above-mentioned ratio of adjuvant, by distilled water, sorbierite, natrium adetate, propylene glycol and step
Supernatant obtained by rapid b is uniformly mixed, and is heated to 90~95 DEG C and is kept the temperature preservation, obtains water phase;
Step d, atoleine, sustained release emulsifier, single glyceryl isostearate, ethylparaben are uniformly mixed, heated
To 85~90 DEG C and preservation is kept the temperature, obtains oil phase;
Step e, the water is mutually added to the speed of 1~3 part/min under the mixing speed of 900~1100r/min
In the oil phase, after stirring 20~25min, continue stirring to mixture temperature under the speed of 500~600r/min and be down to 20
~30 DEG C to get.
Above-mentioned steps a by repeatedly decoct can decoct solution formed funneling effect, accelerate extract in effectively into
The dissolution divided improves extraction efficiency.
To be concentrated under reduced pressure, the relative density for being concentrated into the concentrate is 1.10~1.20 for concentration described in above-mentioned steps b.
Thickening efficiency can be improved using the method being concentrated under reduced pressure, shorten the operating time, the relative density of the concentrate after concentration is
1.10~1.20, it is possible to reduce ethanol consumption if liquid is excessively dilute, need to use substantial amounts of ethyl alcohol, so as to cause to waste, if overrich,
It is present with a large amount of precipitation little Yi package active ingredients during alcohol precipitation, causes damages.
It is further preferred that concentration expressed in percentage by volume >=95% of the ethyl alcohol, the volume of the ethyl alcohol is the concentrate
1~1.5 times of volume, the time of the standing is 20~30h.After adding in ethyl alcohol and staticly settling, low molecule active ingredient
It is still dissolved in dilute alcohol solution, and macromolecule impurity is then precipitated and stays in precipitation, so as to obtain refined supernatant.
In order to better illustrate embodiment of the present invention, illustrated below by embodiment is further.
Embodiment 1
An embodiment of the present invention provides a kind of emulsifiable paste for acne and skin barrier injury repair, including following parts by weight
The raw material of number proportioning:12 parts of oldenlandia diffusa, 12 parts of climbing groundsel, 12 parts of Chinese holly, 12 parts of Chinese violet, 8 parts of felwort, shaggy-fruited dittany
8 parts of skin, 8 parts of barberry, 6 parts of Eucalyptus globulus Labill leaf, 6 parts of peppermint, 10 parts of loguat leaf, 8 parts of wheat bran rhizoma atractylodis, 6 parts of piper cubeba, eclipta charcoal 6
Part, 6 parts of Herba Cistanches, 10 parts of Radix Paeoniae Alba, 8 parts of bush, 8 parts of dragon's blood, 8 parts of catechu.
Further include the auxiliary material of following parts by weight proportioning:51 parts of distilled water, 24 parts of sorbierite, 0.04 part of natrium adetate,
3.5 parts of propylene glycol, 7 parts of atoleine, 2.6 parts of sustained release emulsifier (PEG-30 dimerization hydroxy stearic acid ester), single isostearic acid is sweet
2.6 parts of grease, 0.2 part of ethylparaben.
Preparation method:
Step a, each raw material is weighed by above-mentioned raw materials proportioning, felwort, the root bark of shaggy-fruited dittany, barberry, loguat leaf, wheat bran is grey
Art, piper cubeba, eclipta charcoal, Herba Cistanches, bush, dragon's blood, catechu add the water of 7~10 times of the material quality to decoct 40~50 points
Clock adds in oldenlandia diffusa, climbing groundsel, Chinese violet, Chinese holly, Eucalyptus globulus Labill leaf, peppermint, Radix Paeoniae Alba and continues decoction 10~20 minutes,
Filtering, adds water to cook 1~2 time into filter residue, every time 1~1.5 it is small when, filtering merges all filtrates;
Step b, the concentrate that relative density is 1.10~1.20 is obtained after filtrate decompression is concentrated, addition is equivalent to concentrate
The ethyl alcohol that 1~1.5 times of volume stands 20~30h, and filtering takes supernatant, crosses No. 5 sieves;
Step c, each auxiliary material is weighed by above-mentioned ratio of adjuvant, by distilled water, sorbierite, natrium adetate, propylene glycol and step
Supernatant obtained by rapid b is uniformly mixed, and is heated to 90~95 DEG C and is kept the temperature preservation, obtains water phase;
Step d, atoleine, sustained release emulsifier, single glyceryl isostearate, ethylparaben are uniformly mixed, heated
To 85~90 DEG C and preservation is kept the temperature, obtains oil phase;
Step e, the water is mutually added to the speed of 1~3 part/min under the mixing speed of 900~1100r/min
In the oil phase, after stirring 20~25min, continue stirring to mixture temperature under the speed of 500~600r/min and be down to 20
~30 DEG C to get.
Embodiment 2
An embodiment of the present invention provides a kind of emulsifiable paste for acne and skin barrier injury repair, including following parts by weight
The raw material of number proportioning:13.5 parts of oldenlandia diffusa, 13.5 parts of climbing groundsel, 13.5 parts of Chinese holly, 13.5 parts of Chinese violet, felwort
9 parts, 9 parts of the root bark of shaggy-fruited dittany, 9 parts of barberry, 7 parts of Eucalyptus globulus Labill leaf, 7 parts of peppermint, 11 parts of loguat leaf, 9 parts of wheat bran rhizoma atractylodis, 7 parts of piper cubeba, ink
Non-irrigated 7 parts of lotus charcoal, 7 parts of Herba Cistanches, 11 parts of Radix Paeoniae Alba, 9 parts of bush, 9 parts of dragon's blood, 9 parts of catechu.
Further include the auxiliary material of following parts by weight proportioning:53 parts of distilled water, 26 parts of sorbierite, 0.05 part of natrium adetate,
3.75 parts of propylene glycol, 8 parts of atoleine, sustained release emulsifier (PEG-30 dimerization hydroxy stearic acid ester and Sorbitan Sesquioleate matter
Amount is than being 1:1 mixture) 2.8 parts, single 2.8 parts of glyceryl isostearate, 0.25 part of ethylparaben.
Preparation method:
With embodiment 1.
Embodiment 3
An embodiment of the present invention provides a kind of emulsifiable paste for acne and skin barrier injury repair, including following parts by weight
The raw material of number proportioning:It is 15 parts of oldenlandia diffusa, 15 parts of climbing groundsel, 15 parts of Chinese holly, 15 parts of Chinese violet, 10 parts of felwort, white
10 parts of fresh hide, 10 parts of barberry, 8 parts of Eucalyptus globulus Labill leaf, 8 parts of peppermint, 12 parts of loguat leaf, 10 parts of wheat bran rhizoma atractylodis, 8 parts of piper cubeba, ink drought
8 parts of lotus charcoal, 8 parts of Herba Cistanches, 12 parts of Radix Paeoniae Alba, 10 parts of bush, 10 parts of dragon's blood, 10 parts of catechu.
Further include the auxiliary material of following parts by weight proportioning:55 parts of distilled water, 28 parts of sorbierite, 0.06 part of natrium adetate,
4.0 parts of propylene glycol, 9 parts of atoleine, (PEG-30 dimerization hydroxy stearic acid ester is 1 with poloxamer mass ratio to sustained release emulsifier:
1 mixture) 3.0 parts, single 3.0 parts of glyceryl isostearate, 0.3 part of ethylparaben.
Preparation method:
With embodiment 1.
Zoopery
Subjects:ICR mouse 60, SPF grades, female, weight 18g~22g is randomly divided into 5 groups, i.e. normal control
Group, model group, 1 group of embodiment, 3 groups of embodiment, positive controls, every group 12.In addition to Normal group, remaining each group with
Adhesive tape legal system makes mouse skin mechanical barrier model.Specific method is:Medical adhesive tape is close to the mouse back for removing hair
On skin, torn fast immediately.Every mouse is concentrated modeling twice daily, each quantity of stimulus be 5 times " paste --- tear
Under " flow.When the time interval of focused stimulation is about 8 small.The modeling time amounts to 5 days.Mouse skin after modeling should be rubescent, but
Without hyperemia.
Medication:It is administered after modeling.The medication that 1 group of embodiment be 1 obtained emulsifiable paste of embodiment, embodiment 3
The medication of group is 3 obtained emulsifiable paste of embodiment, and the medication of positive controls is Momestasone furoate cream.Sterile gauze is cut
Square into 1*1cm sizes is spare.With remove needle tubing syringe draw each group correspond to emulsifiable paste, by 1 group of embodiment, 3 groups of embodiment,
The dosage of daily every 0.3g of positive controls, emulsifiable paste is transferred on gauze, then the gauze is applied in mouse skin machine
At tool barrier injury, and pat to promote to absorb.Successive administration 14 days, weighing weight.
Experimental result:
1. moisture content of skin
Moisture content of skin test result part table 1.
Moisture content of skin after the different group mouse of table 1 are administered 14 days
Number | Normal group | Model group | 1 group of embodiment | 3 groups of embodiment | Positive controls |
1 | 41.67 | 41.00 | 42.33 | 43.33 | 41.67 |
2 | 43.33 | 43.33 | 41.67 | 43.00 | 42.67 |
3 | 41.00 | 35.33 | 42.67 | 43.67 | 41.67 |
4 | 39.00 | 43.00 | 43.67 | 43.33 | 42.67 |
5 | 41.67 | 33.67 | 43.00 | 43.33 | 39.67 |
6 | 30.33 | 42.67 | 41.33 | 43.33 | 35.67 |
7 | 43.33 | 39.67 | 43.00 | 42.67 | 43.33 |
8 | 42.33 | 31.67 | 43.33 | 43.67 | 37.33 |
9 | 37.67 | 43.00 | 43.67 | 43.00 | 42.67 |
10 | 43.33 | 33.67 | 43.00 | 43.33 | 39.67 |
11 | 39.00 | 42.67 | 43.33 | 43.33 | 41.00 |
12 | 43.67 | 39.67 | 43.33 | 42.67 | 43.33 |
Average | 40.53 | 39.11 | 42.86 | 43.22 | 40.94 |
SD | 3.77 | 4.33 | 0.74 | 0.33 | 2.44 |
By experimental result as it can be seen that model group is compared with normal group, since skin barrier is damaged water content is caused to decline.Than
Compared with 1 group of embodiment, 3 groups of embodiment and model group, it is known that 1 group of embodiment, the moisture content of skin of 3 groups of embodiment have rising, former
Because being that the emulsifiable paste that embodiment 1, embodiment 3 are provided draws moist and moisture retention with stronger, therefore skin barrier can be damaged
Place keeps certain hydrauture, promotes skin barrier reparation.
2. skin oil and fat content
Skin oil and fat content results are shown in Table 2.Kruskal-Wallis inspections are carried out to 2 result of table, the results are shown in Table 3.
Skin oil and fat content after the different group mouse of table 2 are administered 14 days
3 Kruskal-Wallis of table is examined
Group | N | Order average |
Normal group | 12 | 31.38 |
Model group | 12 | 37.08 |
1 group of embodiment | 12 | 25.13 |
3 groups of embodiment | 12 | 31.08 |
Positive controls | 12 | 27.83 |
Sum | 60 |
By experimental result as it can be seen that model group mouse is because skin barrier is damaged, smegma grease increases compared to normal group,
Increasing for sebum level contributes to closed coat, prevents percutaneous loss of moist.1 group of embodiment, 3 groups of embodiment, positive controls
Compared with model group, sebum level is remarkably decreased, it is possible the reason for be to be administered each group containing drawing wet ingredient, skin external environment
Moisture is sufficient, due to water shortage skin oil and fat will not be caused to secrete.
3. cellular inflammation dielectric tests
Cellular inflammation dielectric tests the results are shown in Table 4.
Skin interleukin 6 content after the different group mouse of table 4 are administered 14 days
Number | Normal group | Model group | 1 group of embodiment | 3 groups of embodiment | Positive controls |
1 | 98.652 | 157.97 | 87.4 | 123.564 | 88.929 |
2 | 144.059 | 83.942 | 67.991 | 145.954 | 69.719 |
3 | 89.627 | 147.221 | 98.367 | 115.646 | 82.156 |
4 | 105.834 | 223.652 | 151.044 | 98.224 | 57.637 |
5 | 124.62 | 114.907 | 141.075 | 70.653 | 48.797 |
6 | 104.388 | 100.365 | 179.356 | 67.328 | 46.395 |
7 | 135.937 | 134.083 | 74.408 | 68.921 | 61.017 |
8 | 128.107 | 112.548 | 172.793 | 77.789 | 91.585 |
9 | 118.171 | 93.693 | 145.006 | 89.208 | 59.323 |
10 | 108.595 | 97.94 | 90.046 | 67.726 | 40.886 |
11 | 142.644 | 139.824 | 80.513 | 93.834 | 40.264 |
12 | 116.536 | 100.508 | 124.469 | 46.774 | |
Average | 118.24 | 126.89 | 115.71 | 95.28 | 61.12 |
In normal group, the sample values that number is 12 are more than reorganization average plus three times variance, therefore are rejected.By testing
As a result as it can be seen that model group is compared with normal group, interleukin 6 content significantly raises, and shows that the destruction of skin barrier has triggered skin
The inflammatory reaction of tissue;1 group of embodiment, 3 groups of embodiment are compared with model group, and the content of interleukin 6 significantly reduces, and shows to implement
The anti-inflammatory effect for the emulsifiable paste that example 1, embodiment 3 are provided plays a role in the repair process of skin barrier, especially with embodiment 3
Effect it is good.
4. ceramide content is tested
Ceramide content test result is shown in Table 5.
Cutaneous nerve amide content after the different group mouse of table 5 are administered 14 days
Statistical test is carried out to above-mentioned experimental result, the results are shown in Table 6, table 7.
6 test of normality of table
*:The lower limit of the true level of signifiance.
7 Multiple range test of table
*:The significance of equal value difference is 0.05.
By experimental result as it can be seen that 1 group of embodiment, 3 groups of embodiment are compared with model group, ceramide content increases.Especially
3 groups of embodiment is compared with model group, P<0.01, there is significant difference.Illustrating that embodiment 3 has more obviously increases epidermis
The effect of middle ceramide content.
5. pathological section
Pathological section, the result is shown in Figure 1~Fig. 5 are carried out to the experiment skin of each group mouse.Wherein, Fig. 1 is in zoopery
The experiment skin of normal group mouse carries out pathological section figure;Fig. 2 is that the experiment skin of model group mouse in zoopery carries out disease
Manage slice map;Fig. 3 is that the experiment skin of 1 group of mouse of embodiment in zoopery carries out pathological section figure;Fig. 4 is in zoopery
The experiment skin of 3 groups of mouse of embodiment carries out pathological section figure;Fig. 5 is the experiment skin of positive control group mice in zoopery
Carry out pathological section figure.
By pathological section result as it can be seen that normally group mouse skin is normal, model group epidermis thickens substantially, and cuticula increases
Thickness, locally there is the mistake of cutin matter break, and cell level increases.Skin corium has an inflammatory cell infiltration, and body cell increases on gland.It is real
Applying 1 group of example, 2 groups of embodiment and positive controls, more than pathological change has different degrees of improvement.
By 1~table of table 5 and Fig. 1~Fig. 5 as it can be seen that embodiment group provided for acne and skin barrier injury repair
Emulsifiable paste have good skin barrier repair.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all essences in the present invention
Any modification, equivalent substitution or improvement made within refreshing and principle etc., should all be included in the protection scope of the present invention.
Claims (10)
1. a kind of emulsifiable paste for acne and skin barrier injury repair, it is characterised in that:Including following parts by weight proportioning
Raw material:12~15 parts of oldenlandia diffusa, 12~15 parts of climbing groundsel, 12~15 parts of Chinese holly, 12~15 parts of Chinese violet, felwort
8~10 parts, it is 8~10 parts of the root bark of shaggy-fruited dittany, 8~10 parts of barberry, 6~8 parts of Eucalyptus globulus Labill leaf, 6~8 parts of peppermint, 10~12 parts of loguat leaf, grey
8~10 parts of art, 6~8 parts of piper cubeba, 6~8 parts of eclipta, 6~8 parts of Herba Cistanches, 10~12 parts of Radix Paeoniae Alba, 8~10 parts of bush, blood
Exhaust 8~10 parts, 8~10 parts of catechu.
2. the emulsifiable paste according to claim 1 for acne and skin barrier injury repair, it is characterised in that:The rough gentian
Grass, the root bark of shaggy-fruited dittany, barberry, loguat leaf, rhizoma atractylodis, piper cubeba, eclipta, Herba Cistanches, bush, dragon's blood, catechu are after processing
Medicinal material, the oldenlandia diffusa, climbing groundsel, Chinese holly, Chinese violet, Eucalyptus globulus Labill leaf, peppermint, Radix Paeoniae Alba are not processing after cleaning
Fresh medicine material.
3. the emulsifiable paste according to claim 2 for acne and skin barrier injury repair, it is characterised in that:The rhizoma atractylodis
For wheat bran rhizoma atractylodis;And/or
The eclipta is eclipta charcoal.
4. according to claims 1 to 3 any one of them for the emulsifiable paste of acne and skin barrier injury repair, feature exists
In:Further include the auxiliary material of following parts by weight proportioning:51~55 parts of distilled water, 24~28 parts of sorbierite, natrium adetate 0.04
~0.06 part, 3.5~4.0 parts of propylene glycol, 7~9 parts of atoleine is sustained 2.6~3.0 parts of emulsifier, single isostearic acid glycerine
2.6~3.0 parts of ester, 0.2~0.3 part of ethylparaben.
5. the emulsifiable paste according to claim 4 for acne and skin barrier injury repair, it is characterised in that:Including following
The auxiliary material of parts by weight proportioning:53 parts of distilled water, 26 parts of sorbierite, 0.05 part of natrium adetate, 3.75 parts of propylene glycol, liquid stone
8 parts of wax, 2.8 parts of PEG-30 dimerization hydroxy stearic acid ester, single 2.8 parts of glyceryl isostearate, 0.25 part of ethylparaben.
6. the emulsifiable paste according to claim 4 for acne and skin barrier injury repair, it is characterised in that:The sustained release
Emulsifier is included at least one of PEG-30 dimerization hydroxy stearic acid ester, Sorbitan Sesquioleate, poloxamer.
7. a kind of existing for acne and the preparation method of the emulsifiable paste of skin barrier injury repair, feature described in claim 4
In, the emulsifiable paste for acne and skin barrier injury repair by the raw material is extracted, filtering, after alcohol precipitation with the auxiliary material
It is mixed with.
8. according to claim 7 exist for acne and the preparation method of the emulsifiable paste of skin barrier injury repair, feature
In specifically including following steps:
Step a, weigh each raw material by any one of claims 1 to 3 raw material proportioning, by felwort, the root bark of shaggy-fruited dittany, barberry,
Loguat leaf, rhizoma atractylodis, piper cubeba, eclipta, Herba Cistanches, bush, dragon's blood, catechu add the water of 7~10 times of the material quality to decoct
40~50 minutes, add in oldenlandia diffusa, climbing groundsel, Chinese violet, Chinese holly, Eucalyptus globulus Labill leaf, peppermint, Radix Paeoniae Alba continue decoction 10~
20 minutes, filtering added water to cook 1~2 time into filter residue, every time 1~1.5 it is small when, filtering merges all filtrates;
Step b, concentrate is obtained after filtrate is concentrated, adds in ethyl alcohol, stands, takes supernatant;
Step c, as described in claim 4, ratio of adjuvant weighs each auxiliary material, by distilled water, sorbierite, natrium adetate, propylene glycol
It is uniformly mixed with step b gained supernatants, is heated to 90~95 DEG C and keeps the temperature preservation, obtain water phase;
Step d, atoleine, sustained release emulsifier, single glyceryl isostearate, ethylparaben are uniformly mixed, are heated to 85
~90 DEG C and preservation is kept the temperature, obtain oil phase;
Step e, the water is mutually added to the speed of 1~3 part/min under the mixing speed of 900~1100r/min described
In oil phase, after stirring 20~25min, continue stirring to mixture temperature under the speed of 500~600r/min and be down to 20~30
DEG C to get.
9. according to claim 8 exist for acne and the preparation method of the emulsifiable paste of skin barrier injury repair, feature
In to be concentrated under reduced pressure, the relative density for being concentrated into the concentrate is 1.10~1.20 for concentration described in step b;And/or
Concentration expressed in percentage by volume >=95% of ethyl alcohol described in step b, the volume of the ethyl alcohol for the volume of the concentrated liquid 1~
1.5 times, the time of the standing is 20~30h.
10. acne drug neck is being prepared for the emulsifiable paste of acne and skin barrier injury repair described in claim any one of 1-3
The application in domain.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810108054.8A CN108114115A (en) | 2018-02-02 | 2018-02-02 | A kind of emulsifiable paste for being used for acne and skin barrier injury repair and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810108054.8A CN108114115A (en) | 2018-02-02 | 2018-02-02 | A kind of emulsifiable paste for being used for acne and skin barrier injury repair and its preparation method and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108114115A true CN108114115A (en) | 2018-06-05 |
Family
ID=62233350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810108054.8A Pending CN108114115A (en) | 2018-02-02 | 2018-02-02 | A kind of emulsifiable paste for being used for acne and skin barrier injury repair and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108114115A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103405698A (en) * | 2013-08-26 | 2013-11-27 | 胡殿宾 | Traditional Chinese medicine liniment for treating acnes and preparation method thereof |
FR3031309A1 (en) * | 2015-01-07 | 2016-07-08 | Cep | COSMETIC AND / OR DERMATOLOGICAL COMPOSITION FOR THE TREATMENT OF SKIN CONDITIONS |
-
2018
- 2018-02-02 CN CN201810108054.8A patent/CN108114115A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103405698A (en) * | 2013-08-26 | 2013-11-27 | 胡殿宾 | Traditional Chinese medicine liniment for treating acnes and preparation method thereof |
FR3031309A1 (en) * | 2015-01-07 | 2016-07-08 | Cep | COSMETIC AND / OR DERMATOLOGICAL COMPOSITION FOR THE TREATMENT OF SKIN CONDITIONS |
Non-Patent Citations (2)
Title |
---|
傅晓丹: "浅谈辨治阳虚型痤疮的临证心得", 《江西中医药》 * |
刘雷 等: "硝酸布康唑缓释乳膏制备工艺的优化及体外释放度考察", 《江苏大学学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104338083A (en) | Medicament for treating irregular menstruation and preparation method thereof | |
CN102772591B (en) | Hollow, ventilation and double-layer traditional Chinese medicine suppository for treating rhinitis and production method of traditional Chinese medicine suppository | |
CN105055849B (en) | Enriching yin Chinese medical extract for nourishing kidney and its preparation method and application | |
CN109939193A (en) | A kind of composition for treating skin eczema, preparation and preparation method and application | |
CN108403932B (en) | Traditional Chinese medicine compound external preparation for treating hormone-dependent dermatitis and preparation method and application thereof | |
CN101164600A (en) | Medicine for treating acne and whelk | |
CN105596861A (en) | Pill used for treating adverse reaction after CT enhancement scanning and preparation method | |
CN109125641A (en) | Compound cortex dictamni ointment and preparation method thereof | |
CN109464517A (en) | Clearing heat and detoxicating paediatrics external application massage ointment formula, the method and application for preparing ointment | |
CN104706953A (en) | Traditional Chinese medicine preparation for treating chronic cervicitis | |
CN114306478B (en) | A Chinese medicinal composition for treating dermatoses | |
CN108114115A (en) | A kind of emulsifiable paste for being used for acne and skin barrier injury repair and its preparation method and application | |
CN105031170A (en) | Healthcare foot bath powder and preparing method thereof | |
CN106822300B (en) | Traditional Chinese medicine preparation for removing acne and beautifying face | |
CN110585379A (en) | External application medicine for treating dermatitis | |
CN104323960A (en) | Traditional Chinese medicine facial mask for removing acne and whitening and preparation method of traditional Chinese medicine facial mask | |
CN110075178A (en) | A kind of composition for treating corticosteroid dermatitis, preparation and preparation method and application | |
CN109481495A (en) | A kind of Chinese medicine compound prescription and preparation method thereof for treating diabetes | |
CN109395050A (en) | Paediatrics external application massage the ointment formula, preparation method and application for treating diarrhea | |
CN108159276A (en) | A kind of fumigation liquid and preparation method thereof and application method | |
CN105770115A (en) | Traditional Chinese medicine ointment for treating eczema | |
CN104666784A (en) | Acne treating capsules and preparation method thereof | |
Chen | Herbology in Three Traditional Medicines for Acne | |
CN104784541B (en) | It is a kind of to be used to remove Chinese drugs agentia of acne and preparation method thereof | |
CN104800629B (en) | A kind of osteophyte-eliminating ointment and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180605 |